|
|
Killer Virus Hits Past Drug Users
URL: http://www.mapinc.org/drugnews/v04/n952/a08.html
Newshawk: JimmyG
Pubdate: Sun, 04 Jul 2004
Source: Observer, The (UK)
Copyright: 2004 The Observer
Contact: letters@observer.co.uk
Website: http://www.observer.co.uk/
Details: http://www.mapinc.org/media/315
Author: Jo Revill, health editor The Observer
Bookmark: http://www.mapinc.org/coke.htm
(Cocaine)
Bookmark: http://www.mapinc.org/find?143
(Hepatitis)
KILLER VIRUS HITS PAST DRUG USERS
Thousands of middle-aged professionals who experimented with drugs
during their student days will be warned in a major government health
campaign this autumn that they may be infected with hepatitis C.
It is thought that up to 400,000 British people may be carrying the
potentially fatal virus without knowing it, because there is such a long
delay between infection and symptoms appearing.
Ministers have decided to go ahead with a national public awareness
campaign in September, warning that anyone who has ever injected drugs,
particularly sharing a needle, used straws to sniff cocaine or had a
blood transfusion before 1991, is at risk and should consider having a
blood test. However, they are worried about causing mass panic and
want to adopt a 'softly-softly' approach by focusing on the treatment
available for the disease, rather than its potential consequences.
The co-ordinators are hoping to find a celebrity who has been infected
with the virus to spearhead the campaign, but so far those approached
have declined publicity, such is the embarrassment associated with the
condition. The general public view about hepatitis C is that only
hardened drug addicts are at risk, but increasingly doctors are seeing
patients who have been infected after just one or two injections.
The virus is passed on through blood-to-blood contact, and those at risk
also include people who had a blood transfusion before blood screening
was brought in 13 years ago. Sexual transmission, tattooing and
piercing are the other possible methods of transmission.
At present only 2,000 people a year are treated for hepatitis C on the
NHS, but estimates of the numbers infected in the UK vary from around
0.4 per cent of the population, some 240,000, to 1 per cent, some
600,000.
It is potentially fatal, but effective new antiviral drugs can cure
between 50 to 80 per cent of sufferers who have a chronic form of the
disease. Of those who carry hepatitis C, about 80 per cent go on
to develop a chronic infection in the liver, and about one-fifth of
these will develop serious liver disease.
However, many people do not know they are carriers until they have
serious symptoms such as severe liver pain. Many of those at risk
will be people who experimented with drugs in their youth. Charles
Gore, chief executive of the Hepatitis C Trust, said: 'How do you reach
the man on the street, who might have had a blood transfusion 20 years
ago, or who might have injected drugs in his youth. and warn him
that he could be wandering around with this virus?'
People can have the disease for 20 years or more before they develop
symptoms, which means those who experimented at college might not
realise the risks.
'Typically, it might be someone who didn't know how to inject drugs into
the vein and who borrowed a syringe from someone who was more
experienced. The virus can then be passed directly into the
bloodstream.'
Gore added: 'Between 1975 and 1985, in particular, there was a huge
experimentation with drugs. It was before the Aids crisis, no one
was aware of the dangers of blood-borne viruses, and many more were
injecting than was commonly supposed.'
Gore, who backs the government's efforts, says that Britain is far
behind other European countries in identifying patients. 'It is
hard to get people to admit that they might be at risk. It
involves them owning up to their past.'
The chair of the Department of Health's advisory group on hepatitis,
Professor Howard Thomas, re-iterated the warning that patients don't
have to be drug addicts to be at risk. 'Many of those infected
will be people in influential positions who dabbled with drugs years ago
while at college,' he told the Health Service Journal last week.
While admitting there is more to be done in making GPs aware of the
disease, he said that they have now taken the first steps in setting up
a national system of clinical centres for hepatology, or liver disease.
The first signs of the disease are not easy to spot. They commonly
include fatigue and aching joints, which are fairly usual for people in
their middle age. Patients also experience differing degrees of
pain. Some have a mild form of the virus and are in acute pain,
others have serious liver damage before they realise anything is wrong.
Ministers, highly aware of how the HIV campaign in the Eighties scared a
generation of people, want to take a more 'softly-softly' approach.
They started last week by sending out an action plan to all GPs and
health professionals.
A spokeswoman for the Department of Health would say little about the
campaign, other than to state that an outside consultancy firm had been
brought in to work on strategy. 'We will have a public awareness
campaign, but in order not to get people panicked, you have to do it in
stages, so the first stage is to make the professionals aware of the
potential problems.'
. For more information, call the Hepatitis C Trust's helpline on
0870 200 1200.
|
|